Expert: Concerns about transparency in AI models

Published: 21 July 2025

A coalition of 40 AI researchers – including signatories from Meta, OpenAI and Montreal-based Mila – has issued a joint position paper warning that as advanced AI systems evolve, we may be losing...

Ancient viruses in our DNA may hold clues to what makes us human

Published: 21 July 2025

Fragments of ancient viral DNA once dismissed as “junk” may play a role in controlling our genes, according to a new international study....

Ricardo Chejfec MPP '21 and Abigail Jackson MPP '23 on Why Canada’s Nation-Building Projects Need a Skills Revolution | Policy Options

Published: 21 July 2025

Abigail Jackson, MPP '23, and Ricardo Chejfec, MPP '21, along with Rachel Samson, co-wrote an article in Policy Options arguing that Canada’s push to accelerate major infrastructure and energy...

8th National Neuromuscular Review Course

Friday, October 24, 2025 09:00toSaturday, October 25, 2025 17:00

Dr. Nicolas Dupré of Laval University, Dr. Karine Garneau of Université de Montréal, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course...

Hughlings Jackson Lecture 2025: The Basal Ganglia and the Motivation to Act

Thursday, November 13, 2025 16:00to17:00

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the...

6th National Course on Sleep Medicine

Friday, November 28, 2025 09:00toSaturday, November 29, 2025 16:00

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.3801 rue University, Montreal, QC, H3A 2B4, CA/neuroCategory: Medicine Research...

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson’s, glioblastoma and dementia  

Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Pages

Back to top